← Open Payments lookup

CLAY VEURINK: Open Payments

NPI 1780390427 · SPARTA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,529 in 140 payments from 17 companies in 2025. Trend: 2023 $113 · 2024 $637 · 2025 $2,529

Food & beverage: $2,405Education: $124
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.21$487
Otsuka America Pharmaceutical, Inc.24$335
Alkermes, Inc.19$306
Neurocrine BioSciences, Inc.12$298
ABBVIE INC.17$252
Teva Pharmaceuticals USA, Inc.16$242
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$190
ViiV Healthcare Company4$106
Janssen Pharmaceuticals, Inc4$78
Vanda Pharmaceuticals Inc.2$68

Products named: COBENFY, ARISTADA, INGREZZA, VRAYLAR, CAPLYTA, REXULTI, ABILIFY ASIMTUFII, APRETUDE.

Industry payments across MO — which companies pay providers there.